Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Eli Lilly’s obesity medication shows excellent results, up to 22.5% weight loss

Tirzepatide  achieved superior weight loss compared to placebo at 72 weeks of treatment in topline results from Eli Lilly and Company's SURMOUNT-1 clinical trial,...

Aspen COVID-19 vaccine plant in South Africa risks closure because of lack of orders

Africa's first COVID-19 vaccination plant, touted last year as a trailblazer for an under-vaccinated continent frustrated by sluggish Western handouts, risks shutting down after...

Bristol Myers Squibb sales grew in Q1 due to growth in line products

Pharmaceutical company, drug maker Bristol Myers Squibb on Friday posted slightly higher-than-expected first-quarter earnings thanks to increased sales of its blood-thinning drug Eliquis and...

AbbVie revenues exceeded forecasts, but fell short of expectations

AbbVie reported on Friday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. AbbVie announced earnings per share of $3.16...

Sales of AstraZeneca’s COVID vaccine exceed forecasts Q1 revenue $11.39 billion

AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by a low-to-mid twenties percentage, but...

Novo Nordisk raises 2022 outlook after strong quarter, shares up

Novo Nordisk targets higher sales and operating profit for the year on the back of projected profit growth in the first quarter thanks to...
spot_img

Expert Articles

spot_img